GGrantIndex
← Leaderboards

Edna Cukierman

Institute For Cancer Research

$8,530,678
Attributed
$11,001,156
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,001,156 · 9

By mechanism

R01$8,396,423 · 3
U54$1,644,894 · 2
R21$741,577 · 2
R25$151,738 · 1
P30$66,524 · 1

Top collaborators

Most similar at Institute For Cancer Research

Same institution · by research overlap

Others in their field

Top investigators on “Extracellular Matrix

Research focus

Extracellular MatrixFibroblastsMalignant NeoplasmsTumorSignal TransductionIn VitroIn VivoCellsBiochemicalStructureProteinsGrowthSamplingTumorigenesisSignal PathwayStromal CellsNeoplastic CellTumor ProgressionPreventPlayProteomicsIntegrins3-DimensionalTissues

Grant awards (35)

Pancreatic cancer-associated fibroblasts: function, detection, and regulation$539,269
R01 · FY2025 · CA · contact PI
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer$417,987
U54 · FY2025 · CA · contact PI
Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development$151,738
R25 · FY2025 · CA · contact PI
Cancer Signaling and Microenvironment Program$66,524
P30 · FY2025 · CA · contact PI
Pancreatic cancer-associated fibroblasts: function, detection, and regulation$497,182
R01 · FY2024 · CA · contact PI
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer$397,088
U54 · FY2024 · CA · contact PI
Pancreatic cancer-associated fibroblasts: function, detection, and regulation$242,249
R01 · FY2024 · CA · contact PI
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$510,277
R01 · FY2023 · CA
Pancreatic cancer-associated fibroblasts: function, detection, and regulation$508,889
R01 · FY2023 · CA · contact PI
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer$411,831
U54 · FY2023 · CA · contact PI
Pancreatic Cancer-Associated Fibroblasts: Function, Detection, and Regulation$254,999
R01 · FY2023 · CA · contact PI
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$521,990
R01 · FY2022 · CA
Pancreatic cancer-associated fibroblasts: function, detection, and regulation$517,107
R01 · FY2022 · CA · contact PI
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer$417,988
U54 · FY2022 · CA · contact PI
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$168,700
R01 · FY2022 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$546,285
R01 · FY2021 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$105,092
R01 · FY2021 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$587,690
R01 · FY2020 · CA
Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells$200,481
R21 · FY2020 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$597,883
R01 · FY2019 · CA
Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells$236,146
R21 · FY2019 · CA
3D-Adhesion Stromagenesis in Cancer Permissiveness$333,377
R01 · FY2016 · CA · contact PI
3D-Adhesion Stromagenesis in Cancer Permissiveness$67,588
R01 · FY2016 · CA · contact PI
3D-Adhesion Stromagenesis in Cancer Permissiveness$334,387
R01 · FY2015 · CA · contact PI
3D-Adhesion Stromagenesis in Cancer Permissiveness$67,588
R01 · FY2015 · CA · contact PI
3D-Adhesion Stromagenesis in Cancer Permissiveness$327,986
R01 · FY2014 · CA · contact PI
3D-Adhesion Stromagenesis in Cancer Permissiveness$231,352
R01 · FY2013 · CA · contact PI
3D-Adhesion Stromagenesis in Cancer Permissiveness$245,775
R01 · FY2012 · CA · contact PI
3D-adhesion stromagenesis in cancer permissiveness$240,604
R01 · FY2010 · CA · contact PI
3D-adhesion stromagenesis in cancer permissiveness$235,778
R01 · FY2009 · CA · contact PI
3D-adhesion stromagenesis in cancer permissiveness$235,778
R01 · FY2008 · CA · contact PI
3D-adhesion stromagenesis in cancer permissiveness$235,778
R01 · FY2007 · CA · contact PI
3D-adhesion stromagenesis in cancer permissiveness$242,820
R01 · FY2006 · CA · contact PI
Primed Stroma: A Tumor Permissive Microenvironment$152,100
R21 · FY2005 · CA
Primed Stroma: A Tumor Permissive Microenvironment$152,850
R21 · FY2004 · CA